We Develop Innovative Healthcare Solutions Through Cannabis & Mushroom Based Sciences About Psilosybin & Cannabinoids Psilocybin – The Active Compound found in various mushrooms. FDA granted “breakthrough therapy” status to psilocybin in 2020. Acknowledgement that Major Depressive Disorder (MDD) represents an unmet medical need and suggests that psilocybin may offer a substantial clinical improvement over existing therapies. Cannabinoids – The active compounds found in Cannabis. Cannabinoids are commonly used to treat seizure disorder, anxiety, pneumonia, dystonia, Parkinson disease, Crohn disease, and many other conditions. Drug Target Discovery Pre-Clinical Trials Clinical Trials FDA Approval The potential for medicinal psychedelics & cannabinoids have never been this big. 100$B Estimated $100B USD global total addressable market for psychedelics. 97$B “The global medical cannabis market size is projected to reach $97.35B USD by the end of 2026.” 42$B Annual substance abuse treatment sales. 17.6$B Annual anxiety, depression & ADHD drug sales. Latest Press Releases Discover The Future We are developing innovative healthcare solutions for humanity. We believe in improving the lives of all our consumers through solid scientific research. CONTACT US © Copyright M2BIO SCIENCES INC 2020 | ALL RIGHTS RESERVED Facebook Twitter Instagram